Schonfeld Strategic Advisors LLC Has $355,000 Stock Holdings in DocuSign, Inc. (NASDAQ:DOCU)

Schonfeld Strategic Advisors LLC reduced its stake in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 90.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,950 shares of the company's stock after selling 35,898 shares during the period. Schonfeld Strategic Advisors LLC's holdings in DocuSign were worth $355,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in DOCU. Kestra Investment Management LLC acquired a new stake in shares of DocuSign in the fourth quarter worth $30,000. First Horizon Advisors Inc. lifted its position in DocuSign by 102.6% during the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company's stock worth $36,000 after acquiring an additional 201 shares during the last quarter. Bessemer Group Inc. boosted its holdings in DocuSign by 490.0% during the fourth quarter. Bessemer Group Inc. now owns 472 shares of the company's stock valued at $42,000 after acquiring an additional 392 shares during the period. Avion Wealth boosted its holdings in DocuSign by 309.2% during the fourth quarter. Avion Wealth now owns 487 shares of the company's stock valued at $43,000 after acquiring an additional 368 shares during the period. Finally, Avior Wealth Management LLC grew its position in shares of DocuSign by 36.5% in the fourth quarter. Avior Wealth Management LLC now owns 542 shares of the company's stock valued at $49,000 after purchasing an additional 145 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the company. HSBC raised DocuSign from a "reduce" rating to a "hold" rating and set a $70.00 price objective for the company in a research report on Friday, April 11th. Citigroup upped their target price on shares of DocuSign from $113.00 to $115.00 and gave the company a "buy" rating in a research note on Friday, March 14th. Jefferies Financial Group decreased their price target on shares of DocuSign from $115.00 to $105.00 and set a "buy" rating on the stock in a research report on Monday, March 31st. JPMorgan Chase & Co. raised shares of DocuSign from an "underweight" rating to a "neutral" rating and upped their price objective for the company from $70.00 to $75.00 in a research report on Monday, March 10th. Finally, UBS Group reduced their target price on shares of DocuSign from $90.00 to $85.00 and set a "neutral" rating for the company in a research note on Thursday, April 17th. One analyst has rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, DocuSign presently has a consensus rating of "Hold" and an average price target of $92.46.

Insider Activity

In other news, insider Robert Chatwani sold 15,706 shares of the business's stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $83.19, for a total transaction of $1,306,582.14. Following the completion of the sale, the insider now owns 76,842 shares in the company, valued at $6,392,485.98. The trade was a 16.97% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Blake Jeffrey Grayson sold 8,000 shares of the company's stock in a transaction on Friday, February 14th. The shares were sold at an average price of $86.90, for a total value of $695,200.00. Following the transaction, the chief financial officer now directly owns 77,851 shares in the company, valued at $6,765,251.90. This trade represents a 9.32% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 55,851 shares of company stock worth $4,607,439. 1.66% of the stock is owned by corporate insiders.

DocuSign Stock Performance

Shares of NASDAQ:DOCU traded down $0.07 on Wednesday, hitting $90.27. The stock had a trading volume of 1,763,449 shares, compared to its average volume of 2,746,689. The firm's 50 day moving average price is $80.47 and its 200-day moving average price is $84.75. DocuSign, Inc. has a twelve month low of $48.70 and a twelve month high of $107.86. The company has a market capitalization of $18.28 billion, a price-to-earnings ratio of 18.61, a price-to-earnings-growth ratio of 6.94 and a beta of 1.21.

DocuSign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings data on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.02. The company had revenue of $776.25 million during the quarter, compared to analyst estimates of $760.94 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The company's revenue was up 9.0% on a year-over-year basis. During the same quarter last year, the business posted $0.76 earnings per share. As a group, sell-side analysts predict that DocuSign, Inc. will post 1.17 EPS for the current year.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.